Background and aims: Insulin-like Growth Factors (IGF-1) plays as mediator between metabolic syndrome (MetS), oxidative stress and breast cancer (BrCa) progression. The objective of this study was to examine the relationships between IGF-1 serum levels and metabolic profile biomarkers in a population group of BrCa patients
Insulin-like growth factor I (IGF-I) stimulates cell proliferation and can enhance the development o...
High circulating insulin-like growth factor 1 (IGF-1) levels are firmly established as a risk factor...
Prospective studies have shown an association between elevated plasma levels of insulin-like growth ...
Purpose: Circulating insulin-like growth factor-1 (IGF-1) is positively associated with the risk of ...
SummaryBackgroundInsulin-like growth factor 1 (IGF1) stimulates mitosis and inhibits apoptosis. Some...
BackgroundCirculating lipids and insulin-like growth factor 1 (IGF-I) have been reliably associated ...
The associations between serum concentrations of insulin-like growth factor-I (IGF-I), IGF-II and IG...
Objective Insulin-like growth factor (IGF)-axis is involved in human oncogenesis and metastasis deve...
Objective: High as well as low levels of IGF1 have been associated with cardiovascular diseases (CVD...
Background: The association between metabolic syndrome (MetS) and breast cancer may significantly im...
Background: Earlier data support the hypothesis that the relation between circulating insulin-like g...
Metabolic syndrome is a cluster of risk factors that lead to cardiovascular morbidity and mortality....
Objective: To examine the possible relationships of breast cancer risk to prediagnostic plasma level...
Blood concentrations of insulin-like growth factor-I (IGF-I) and insulin-like growth factor binding ...
"Increased insulin-like growth factor (igf) signalling. has been observed in breast cancer, includin...
Insulin-like growth factor I (IGF-I) stimulates cell proliferation and can enhance the development o...
High circulating insulin-like growth factor 1 (IGF-1) levels are firmly established as a risk factor...
Prospective studies have shown an association between elevated plasma levels of insulin-like growth ...
Purpose: Circulating insulin-like growth factor-1 (IGF-1) is positively associated with the risk of ...
SummaryBackgroundInsulin-like growth factor 1 (IGF1) stimulates mitosis and inhibits apoptosis. Some...
BackgroundCirculating lipids and insulin-like growth factor 1 (IGF-I) have been reliably associated ...
The associations between serum concentrations of insulin-like growth factor-I (IGF-I), IGF-II and IG...
Objective Insulin-like growth factor (IGF)-axis is involved in human oncogenesis and metastasis deve...
Objective: High as well as low levels of IGF1 have been associated with cardiovascular diseases (CVD...
Background: The association between metabolic syndrome (MetS) and breast cancer may significantly im...
Background: Earlier data support the hypothesis that the relation between circulating insulin-like g...
Metabolic syndrome is a cluster of risk factors that lead to cardiovascular morbidity and mortality....
Objective: To examine the possible relationships of breast cancer risk to prediagnostic plasma level...
Blood concentrations of insulin-like growth factor-I (IGF-I) and insulin-like growth factor binding ...
"Increased insulin-like growth factor (igf) signalling. has been observed in breast cancer, includin...
Insulin-like growth factor I (IGF-I) stimulates cell proliferation and can enhance the development o...
High circulating insulin-like growth factor 1 (IGF-1) levels are firmly established as a risk factor...
Prospective studies have shown an association between elevated plasma levels of insulin-like growth ...